Our joint publication with authors from the Basel University – Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2 was just published in IJMS journal. The high similarity between Mpro and human proteases can limit drugs developed against Mpro due to off-targeting and the side effects.